Canada Biotechnology Stock News
Categories
- All
- Editor's Picks
- Q&A with Gurus
- Gurus' Stock Picks
- Insider Transaction
- Earning Reports
- CEO Shareholder Letters
- Press Release
- Earnings Call Transcripts
- Podcast
Industries
- Aerospace & Defense
- Agriculture
- Asset Management
- Banks
- Beverages - Alcoholic
- Beverages - Non-Alcoholic
- Biotechnology
- Building Materials
- Business Services
- Capital Markets
- Chemicals
- Conglomerates
- Construction
- Consumer Packaged Goods
- Credit Services
- Diversified Financial Services
- Drug Manufacturers
- Education
- Farm & Heavy Construction Machinery
- Forest Products
- Furnishings, Fixtures & Appliances
- Hardware
- Healthcare Plans
- Healthcare Providers & Services
- Homebuilding & Construction
- Industrial Distribution
- Industrial Products
- Insurance
- Interactive Media
- Manufacturing - Apparel & Accessories
- Media - Diversified
- Medical Devices & Instruments
- Medical Diagnostics & Research
- Medical Distribution
- Metals & Mining
- Oil & Gas
- Other Energy Sources
- Packaging & Containers
- Personal Services
- Real Estate
- REITs
- Restaurants
- Retail - Cyclical
- Retail - Defensive
- Semiconductors
- Software
- Steel
- Telecommunication Services
- Tobacco Products
- Transportation
- Travel & Leisure
- Utilities - Independent Power Producers
- Utilities - Regulated
- Vehicles & Parts
- Waste Management
GuruFocus News Biotechnology
AbCellera Biologics Inc (ABCL) Q3 2024 Earnings Call Highlights: Navigating Challenges with Strategic Developments
Despite a widened net loss, AbCellera Biologics Inc (ABCL) strengthens its pipeline and partnerships, maintaining robust liquidity for future growth. Nov 05, 2024
GuruFocus News Biotechnology
Theratechnologies Inc (THTX) Q3 2024 Earnings Call Highlights: Strong Profitability Amid Manufacturing Challenges
Theratechnologies Inc (THTX) reports robust earnings with a net profit of $3 million, despite facing supply constraints and competitive pressures. Oct 11, 2024
GuruFocus News Biotechnology
ImmunoPrecise Antibodies Ltd (IPA) Q4 2024 Earnings Call Highlights: Record Revenue Growth Amid Strategic Challenges
ImmunoPrecise Antibodies Ltd (IPA) reports a 19% revenue increase and significant cash burn reduction, while navigating profitability pressures and market valuation disconnects. Oct 09, 2024
GuruFocus Research Biotechnology
ImmunoPrecise Antibodies Ltd (IPA) Q1 2025 Earnings Call Transcript Highlights: Revenue Growth and Strategic Investments Amid Challenges
Despite a year-over-year revenue decline, IPA shows promising growth in key labs and strategic advancements in AI-driven technologies. Sep 17, 2024